Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Beyond the hype: some uncomfortable questions 'Weight loss drugs should not be seen as a silver bullet for weight loss they do not come without risk, and there is no one-size-fits-all approach to tackling obesity.' Prof Kamila Hawthorne, Chair of Royal College of GPs Although GLP-1 medications can be promising pharmacological tools for weight management, their increasing prominence raises several important ethical and public health concerns
Peak symptoms don't mean something is wrong
Consensus expects robust EPS growth (+43% in FY26), but risks include GLP-1 therapy persistence and postmarketing requirements for Foundayo
PubMed laboratory research record [PMID: 36691308] PubMed record related to this compound for laboratory literature review
